Difference between revisions of "CT Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
m
(25 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
:Chairs: Gregory Goldmacher, MD, PhD, MBA (Co-Chair), Lawrence Schwartz, MD (Co-chair), David Lynch, MD (Vice-chair)
+
Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE;  James L. Mulshine, MD
:Secretary: Susan Weinmann (RSNA Staff)
+
<br />RSNA Staff Support: Julie Lisiecki 
::[[Media:QIBA_CT_CC_Voting_Members_Roster.pdf|CT Coordinating Committee Voting Members]]
+
* [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster''']
 +
 
  
 
==Scope==  
 
==Scope==  
Line 15: Line 16:
 
==Meetings==
 
==Meetings==
  
* Tcons are held Quarterly. Contact the secretary for details.
+
* WebEx calls are held Quarterly. Please contact RSNA Staff for details.

Revision as of 23:33, 24 February 2021

Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
RSNA Staff Support: Julie Lisiecki


Scope

The CT Coordinating Committee coordinates Biomarker Committees based on CT.

  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the CT Biomarker Committees

Meetings

  • WebEx calls are held Quarterly. Please contact RSNA Staff for details.